14 results
424B3
XBP
XBP Europe Holdings Inc
13 Feb 24
Prospectus supplement
4:31pm
.
Research and Development
The Company’s ability to compete successfully depends heavily upon its ability to ensure a timely flow of competitive products … of Presentation and Summary of Significant Accounting Policies (cont.)
Research and Development
Research and development costs are expensed as incurred
424B5
p5gbh1v8wn46j6 ugb
29 Nov 23
Prospectus supplement for primary offering
4:44pm
CORRESP
ru2kevqk9u5hq
12 May 23
Correspondence with SEC
12:00am
425
EX-2.1
dglstwhqyh
11 Oct 22
Business combination disclosure
6:07am
8-K
EX-2.1
rb3fl xlvx
11 Oct 22
Exela Technologies Inc.’s European business to go Public Through Merger with CF Acquisition Corp. VIII
6:05am
- Prev
- 1
- Next